Remote surgery goes mainstream — China's Toumai robot wins EU approval after a London doctor operates on a patient 1,500 miles away

The Toumai robot from Chinese firm MedBot has officially received EU approval, marking a significant milestone in remote surgery technology. This breakthrough came after a London doctor successfully performed a prostate cancer operation on a patient located 1,500 miles away, demonstrating the robot's capability to enable surgeries across vast distances. This advancement could revolutionize how medical procedures are conducted, especially in remote or underserved areas, by allowing expert surgeons to operate from afar. The implications are vast, potentially reducing healthcare disparities and increasing access to specialized surgical care globally.